Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients

BACKGROUND: Early diagnosis of hepatocellular carcinoma (HCC) is necessary to improve the prognosis of patients. However, the currently available tumor biomarkers are insufficient for the early detection of HCC. Acylcarnitine is essential in fatty acid metabolic pathways. A recent study reported tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaya, Hiroaki, Namisaki, Tadashi, Kitade, Mitsuteru, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Nakanishi, Keisuke, Noguchi, Ryuichi, Fujinaga, Yukihisa, Sawada, Yasuhiko, Saikawa, Soichiro, Sato, Shinya, Kawaratani, Hideto, Moriya, Kei, Akahane, Takemi, Yoshiji, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815927/
https://www.ncbi.nlm.nih.gov/pubmed/31662827
http://dx.doi.org/10.4251/wjgo.v11.i10.887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815927/
https://www.ncbi.nlm.nih.gov/pubmed/31662827
http://dx.doi.org/10.4251/wjgo.v11.i10.887

Ejemplares similares